Suchergebnisse - "Itolizumab"

PubPharm (7)

1

Adverse drug reactions of itolizumab in COVID-19 patient : A case report

enthalten in: Indian journal of pharmacology | 2022

von Mohammed, Z. | Suryachandra, K. | Dandekar, M.

2

Monoclonal Antibodies vs COVID-19 : Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center

enthalten in: MEDICC review | 2021

von Aguilar, T. | Gorry, C.

3

Anti-CD6 mAbs for the treatment of psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Dogra, S. | D, S. | Rajagopalan, M.

4

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

enthalten in: Gerontology | 2020

von Díaz, Y. | Ramos-Suzarte, M. | Martín, Y. | +17

5

Itolizumab, a novel anti-CD6 monoclonal antibody : a safe and efficacious biologic agent for management of psoriasis

enthalten in: Expert opinion on biological therapy | 2017

von Dogra, S. | Uprety, S. | Suresh, S.

6

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

enthalten in: PloS one | 2017

von Bughani, U. | Saha, A. | Kuriakose, A. | +11

ErratumIn: PLoS One. 2018 Jan 30;13(1):e0192335. - PMID 29381749

7

Therapeutic Targeting of CD6 in Autoimmune Diseases : A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab

enthalten in: Current drug targets | 2016

von Hernández, P. | Moreno, E. | Aira, L. | +1

1
[1]